Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring

Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. Those hard-to-treat diseases include malaria, tuberculosis, dengue fever, and other conditions. That's the topic of the cover story scheduled for the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

Just about one-third of people seeking malaria treatment in Kenya received the recommended artemisinin-based combination therapies (ACTs) and some people are being treated with ineffective drugs like chloroquine, which was phased out almost 10 years ago, according to the recently launched 2007 Kenya Malaria Indicator Survey - the country's "first ever comprehensive malaria study," the

Boston Globe columnist Derrick Jackson examines why some Ugandans do not support indoor spraying of DDT to prevent malaria. Grace Kagoro, a biology professor and environmental researcher at Mbarara University of Science and Technology, is "nervous about adding what she said could be one more shock to the soil and water," according to Jackson.

In one of the most field-intensive efforts to explore the connection between malaria and tropical deforestation, a team led by Jonathan Patz, a specialist in the link between environment and health at the Nelson Institute for Environmental Studies at the University of Wisconsin-Madison, has established a strong correlation between the extent of forest destruction and the incidence of the Amazon's most dangerous malaria vector, the mosquito Anopheles darlingi.

In malaria-endemic areas, vitamin A supplements - which cost about 2 U.S. cents each - can help reduce infections in children by one-third, according to a study published in the Malaria Journal, IRIN reports.

In malaria-endemic areas, vitamin A supplements - which cost about 2 U.S. cents each - can help reduce infections in children by one-third, according to a study published in the Malaria Journal, IRIN reports. The study analyzed results from previous studies conducted in Burkina Faso, Ghana and Papua New Guinea since 1995.

VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports.

There was more than a 50 percent drop in the total number of malaria cases reported by public facilities in Cambodia between 2003 and 2008, according to the National Centre for Parasitology, Entomology and Malaria Control's annual report, which was released on Tuesday, the Phnom Penh Post reports.